相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
Yohan Lee et al.
BMC MEDICAL GENOMICS (2008)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma
Martin Tepel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss
Markus J. Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene Expression Profiling of NF-1-Associated and Sporadic Pilocytic Astrocytoma Identifies Aldehyde Dehydrogenase I Family Member L1 (ALDHIL1) as an Underexpressed Candidate Biomarker in Aggressive Subtypes
Fausto J. Rodriguez et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma
Eli E. Bar et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas
H. Deshmukh et al.
ONCOGENE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Combined 1p/19q loss in oligodendroglial tumors: Predictive or prognostic biomarker?
Michael Weller et al.
CLINICAL CANCER RESEARCH (2007)
DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in human gliomas
Annegret Kunitz et al.
BRAIN PATHOLOGY (2007)
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q
B. Tews et al.
ONCOGENE (2007)
Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors
Jean-Louis Boulay et al.
PLOS ONE (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P. Cahill et al.
CLINICAL CANCER RESEARCH (2007)
Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas
R. G. Weber et al.
ONCOGENE (2007)
Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas
Mingqi Qu et al.
ACTA NEUROPATHOLOGICA (2007)
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma
W. Mueller et al.
ONCOGENE (2007)
Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors
Detlef Trost et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Aberrant hypermethylation of p14(ARF) and O-6-methylguanine-DNA methyltransferase genes in astrocytoma progression
Takao Watanabe et al.
BRAIN PATHOLOGY (2007)
Significance of necrosis in grading of oligodendroglial neoplasms: A clinicopathologic and genetic study of newly diagnosed high-grade gliomas
C. Ryan Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
Robert B. Jenkins et al.
CANCER RESEARCH (2006)
Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss
Constance A. Griffin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
Ulrich Herrlinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling
Markus J. Riemenschneider et al.
CANCER RESEARCH (2006)
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
C Hunter et al.
CANCER RESEARCH (2006)
Progressive low-grade oligodendrogliomas -: Response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression
N Levin et al.
CANCER (2006)
Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma
F Mendrzyk et al.
CLINICAL CANCER RESEARCH (2006)
The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making
AA Kanner et al.
JOURNAL OF NEUROSURGERY (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration
J. Matthew McDonald et al.
CANCER BIOLOGY & THERAPY (2006)
In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation
MJ Riemenschneider et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Molecular classification of human gliomas using matrix-based comparative genomic hybridization
P Roerig et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Survival analysis of presumptive prognostic markers among oligodendrogliomas
RE McLendon et al.
CANCER (2005)
Radial glia cells are candidate stem cells of ependymoma
MD Taylor et al.
CANCER CELL (2005)
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss
J. Matthew McDonald et al.
MOLECULAR CANCER (2005)
Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma
DW Hamilton et al.
CANCER LETTERS (2005)
Chromosome 1p loss:: A favorable prognostic factor in low-grade gliomas
M Kujas et al.
ANNALS OF NEUROLOGY (2005)
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma
M Alaminos et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epigenetic silencing of the protocadherin family member PCDH-γ-A11 in astrocytomas
A Waha et al.
NEOPLASIA (2005)
Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors
M Möllemann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epidemiology and etiology of gliomas
H Ohgaki et al.
ACTA NEUROPATHOLOGICA (2005)
MGMT: Its role in cancer aetiology and cancer therapeutics
SL Gerson
NATURE REVIEWS CANCER (2004)
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas
KB Fallon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Oligodendroglial tumors: Refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival
J Felsberg et al.
BRAIN PATHOLOGY (2004)
Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas
MJ Riemenschneider et al.
ACTA NEUROPATHOLOGICA (2004)
Gene expression profiling of gliomas strongly predicts survival
WA Freije et al.
CANCER RESEARCH (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions
K Hoang-Xuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytornas:: Biallelic inactivation of TSC1 or TSC2 leads to rnTOR activation
JA Chan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Parental 19q loss and PEG3 expression in oligodendrogliomas
O Trouillard et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Molecular pathogenesis of oligodendroglial tumors
JWM Jeuken et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Pathology and molecular genetics of astrocytic gliomas
G Reifenberger et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas
M Mizoguchi et al.
BRAIN PATHOLOGY (2004)
Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas
A Ohnishi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas
MB Mahler-Araujo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells
C Bouvier et al.
JOURNAL OF NEUROSURGERY (2003)
Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas
ME Alonso et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target
MJ Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
p190RhoGAP can act to inhibit PDGF-induced gliomas in mice:: a putative tumor suppressor encoded on human chromosome 19q13.3
RM Wolf et al.
GENES & DEVELOPMENT (2003)
Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology
G Reifenberger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age
A Korshunov et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
CDKN2A, CDKN2B and p14(ARF) are frequently and differentially methylated in ependymal tumours
E Rousseau et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas
K Kaulich et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups
S Dyer et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas
K Wimmer et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
No chromosomal imbalances detected by comparative genomic hybridisation in subependymal giant cell astrocytomas
CH Rickert et al.
ACTA NEUROPATHOLOGICA (2002)
Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components
B Actor et al.
GENES CHROMOSOMES & CANCER (2002)
Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH
JWM Jeuken et al.
JOURNAL OF PATHOLOGY (2002)
Transcriptional inactivation of TP73 expression in oligodendroglial tumors
SM Dong et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Genetic abnormalities detected in genomic hybridisation epenclymomas by comparative
M Carter et al.
BRITISH JOURNAL OF CANCER (2002)
Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade oligodendroglioma
H Sasaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes
M Wolter et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?
PC Burger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
K Hoang-Xuan et al.
NEUROLOGY (2001)
Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas
L Kluwe et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors
SM Dong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis
H Sasaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma
C Giannini et al.
NEUROGENETICS (2001)
Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups
Y Hirose et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Loss of heterozygosity on chromosome 19 in secondary glioblastomas
M Nakamura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
JS Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Genetic profile of gliosarcomas
RM Reis et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
